Am J Transplant, Volume 21, Suppl 3 Archives - Page 19 of 139 - ATC Abstracts

2021 American Transplant Congress
Not Quite Right: The Irony of Longer Cold Times for Higher KDPI Kidneys
H. Ghali¹, D. Won¹, S. Yoon¹, A. Friedman²
¹Systems Science and Industrial Engineering, SUNY Binghamton, Binghamton, NY, ²LiveOnNY, New York, NY
*Purpose: To identify tactics for reduction of the kidney discard rate, we analyzed measurable, operational factors contributing to the key outcome of transplantation (TXP) or…
2021 American Transplant Congress
Excellent Outcomes of Kidney Transplantation from Hepatitis C Infected Donors
B. Rawashdeh, J. Dann, K. M. Marsh, A. Doddi, S. Rao, A. Agarwal
UVA Health System, University of Virginia, Charlottesville, VA
*Purpose: Utilization of Hepatitis C viremic (HCV D+) kidney donors in HCV naïve recipients has increased in the United States. While there are shorter waiting…
2021 American Transplant Congress
Ambient Air Pollution and Changes in Cognitive Function Among Kidney Transplant Recipients
Y. Feng¹, M. Jones², N. Chu², D. Segev¹, M. McAdams Demarco¹
¹Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, ²Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
*Purpose: Although cognitive function among kidney failure patients improves after kidney transplant (KT), cognitive impairment is common and associated with worse post-KT outcomes. Particulate matter…
2021 American Transplant Congress
Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City
K. Khalil, S. Jonchhe, J. Stern, T. C. Lewis, N. Alnazari, B. Lonze, Z. Stewart Lewis, N. Ali
Transplant Institute, NYU Langone Health, New York, NY
*Purpose: As an early epicenter in the coronavirus pandemic, our center modified induction immunosuppression strategies for transplantation. We sought to determine if changes in induction…
2021 American Transplant Congress
Screening, Management and Acceptance of Patients with Aortoiliac Vascular Disease for Kidney Transplantation: An International Survey Among Transplant Surgeons
E. Rijkse¹, H. J. Kimenai¹, F. J. Dor², J. N. IJzermans³, R. C. Minnee¹
¹HPB/Transplant Surgery, Erasmus Medical Center, Rotterdam, Netherlands, ²Imperial College Transplant Centre, Hammersmith Hospital, London, United Kingdom, ³HPB/Transplant surgery, Erasmus Medical Center, Rotterdam, Netherlands
*Purpose: Aortoiliac vascular disease (AVD) is frequently observed during the work-up for kidney transplantation, but recommendations on its screening and management are lacking. We aimed…
2021 American Transplant Congress
Cost Savings Initiative with Idea Body Weight Dosing of Rabbit Anti-thymocyte Globulin (rATG) Induction in an Older Kidney Transplant Population: A Single Center Analysis
C. LaFratte¹, S. Witek¹, D. Sawinski², J. Trofe-Clark², C. Sammons², B. Hardek¹, R. Samudralwar¹, A. Forte¹, S. Lyle¹, J. Rashid¹, G. Malat²
¹Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia, PA, ²Penn Transplant Institute, Hospital of Univ of Pennsylvania, Philadelphia, PA
*Purpose: Optimal dosing schemes for rATG induction are not well defined for older kidney transplant recipients (KTRs), who are at greater risk for adverse events…
2021 American Transplant Congress
Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation
T. Le¹, J. Shoji², J. Phillips¹, D. Quan¹
¹Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, ²Transplant Nephrology, UCSF Medical Center, San Francisco, CA
*Purpose: Belatacept, a selective T lymphocyte co-stimulation blocker, has been shown to be a safe and effective maintenance therapy for immunosuppression. We investigated the long-term…
2021 American Transplant Congress
The Impact of Diabetes on Young Transplant Recipients: An American Perspective
J. M. Loera, S. C. Barrett, T. S. Zhang, A. A. Awan, B. V. Murthy, R. T. Cotton, C. A. O'Mahany, N. T. Galvan, J. A. Goss, A. A. Rana
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Our study aims to demonstrate the impact of diabetes, types I and II, on American young adults (18-40 years old) requiring kidney transplantation.*Methods: Using…
2021 American Transplant Congress
Alterations in Mineral Metabolism of Living Kidney Donors: Prospective Observational Study
H. Lee¹, E. Ko¹, H. Cho², C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of, ²Department of Urology, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study is to investigate whether reduction in glomerular filtration rate (GFR) after kidney donation causes mineral metabolism alterations, and also…
2021 American Transplant Congress
Is There a Role for Pre-Operative Angiographic Kidney Embolization Prior to Allograft Nephrectomy?
M. Jacobs¹, R. Stratta¹, D. Harriman², A. Farney¹, J. Rogers¹, G. Orlando¹, A. Reeves-Daniel¹, C. Jay¹
¹Wake Forest Baptist Health, Winston Salem, NC, ²University of British Columbia, Vancouver, BC, Canada
*Purpose: To determine if morbidity associated with allograft nephrectomy (AN) of a failed or diseased kidney transplant (KT) is improved by pre-operative angiographic kidney embolization…